Related Experiment Video
Updated: Jun 14, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Chapter 11 - Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges
Andrea M Brioschi1, Sara Calderoni, Gian Paolo Zara
1Department of Neurology and Laboratory of Clinical Neurobiology, Ospedale S. Giuseppe, Istituto Auxologico Italiano, IRCCS, Verbania, Italy. a.brioschi@auxologico.it
Abstract:
Malignant gliomas, despite aggressive multimodal therapies and adequate supportive care, still maintain poor prognosis. Solid lipid nanoparticles (SLN) are colloidal carriers that could be regarded as a highly flexible platform for brain tumor imaging and therapeutical purposes. In this chapter we will first describe brain tumors characteristics and conventional therapeutical approaches. In the subsequent sections, we will analyze SLN properties, effectiveness, and future perspectives in both imaging and targeted treatment of malignant gliomas.

